National survey of fibrinogen concentrate usage for post-partum hemorrhage in Japan: Investigated by the Perinatology Committee, Japan Society of Obstetrics and Gynecology

Journal of Obstetrics and Gynaecology Research

Volumn 41, Issue 8, 2015, Pages 1155-1160

  Makino, Shintaro ^a,b   Takeda, Satoru ^a,b   Kobayashi, Takao ^a,c   Murakami, Maki ^a,d   Kubo, Takahiko ^a,e   Hata, Toshiyuki ^a,f   Masuzaki, Hideaki ^a,g  

^a Japan Society of Obstetrics and Gynecology   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HAMAMATSU MEDICAL CENTER   (Japan)

^d Department of Obstetrics and Gynecology Aiwa Hospital   (Japan)

^e NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^f KAGAWA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

disseminated intravascular coagulation; fibrinogen concentrate; fibrinogen level; national survey; post partum hemorrhage

Indexed keywords

FIBRINOGEN; FIBRINOGEN CONCENTRATE; HEMOSTATIC AGENT;

AMNION FLUID EMBOLISM; BLOOD TRANSFUSION; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE RESPONSE; DRUG FATALITY; FEMALE; FIBRINOGEN BLOOD LEVEL; GYNECOLOGY; HEALTH SURVEY; HEMOSTASIS; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; MEDICAL SOCIETY; MEDICAL SPECIALIST; OBSTETRICS; PERINATOLOGY; POSTPARTUM HEMORRHAGE; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; THROMBOEMBOLISM; TREATMENT RESPONSE; UTERINE ATONY; PREGNANCY; QUESTIONNAIRE;

FEMALE; FIBRINOGEN; HEMOSTATICS; HUMANS; JAPAN; POSTPARTUM HEMORRHAGE; PREGNANCY; RETROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES;

EID: 84938214791     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/jog.12708     Document Type: Review

References (11)

1. Japan Association of Obstetricians and Gynecologists. Japanese Maternal Death Registration investigated by Japan Association of Obstetricians and Gynecologists, 2010-2012. 2013. [Cited August 2013.] Available from URL: http://www.jaog.or.jp/all/document/67-130710.pdf (In Japanese.)
2. Charles J, Lockwood MD,. Pregnancy-associated changes in the hemostatic system. Clin Obstet Gynecol 2006; 49: 836-843.
3. Burtelow M, Riley E, Druzin M, Fontaine M, Viele M, Goodnough LT,. How we treat: Management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion 2007; 47: 1564-1572.
4. Charbit B, Mandelbrot L, Samain E, et al,. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5: 266-273.
5. Levi M, Toh CH, Thachil J, Watson HG,. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 2009; 145: 24-33.
6. Ducloy-Bouthors A-S, Blondé-Zoonekynd E, Jaillette E, et al,. Transfusion and postpartum haemorrhage. Transfus Clin Biol 2010; 17: 273-278.
7. ACOG. Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, 2006: Postpartum hemorrhage.
8. Kikuchi M, Itakura A, Miki A, Nishibayashi M, Ikebuchi K, Ishihara O,. Fibrinogen concentrate substitution therapy for obstetric hemorrhage complicated by coagulopathy. J Obstet Gynaecol Res 2013; 39: 770-776.
9. Kobayashi T., Obstetrical disseminated intravascular coagulation score. J Obstet Gynaecol Res 2014; 40: 1500-1506.
10. Hiippala ST, Myllylä GJ, Vahtera EM,. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360-365.
11. Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M,. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: Results from a randomized, placebo-controlled trial. J Thorac Cardiovasc Surg 2013; 145 (3 Suppl): S178-S185.